Patent application number | Description | Published |
20120214874 | PHARMACEUTICAL FORMULATIONS AND METHODS OF USE - In one embodiment, the present invention provides a topical composition including a topically acting anesthetic active ingredient; an ester; a non-ionic surfactant; a polar solvent; water, and optionally a buffer, a pH adjusting agent or an anti-oxidant. The compositions are useful for alleviating pain especially associated with acute herpes zoster. | 08-23-2012 |
20120309843 | HIGHLY PERMEATING TERBINAFINE FORMULATION - The present invention provides topical compositions, methods of preparation, and methods of treatment for onychomychosis. In certain specific embodiments, the invention provides an anti-fungal pharmaceutical composition for topical application comprising an anti-fungal agent, a zwitterionic surfactant or charged derivative thereof; a carboxylic acid, a lower alcohol, and water. The acid is selected from a short-chain hydroxy acid, a short-chain fatty acid, and a mixture thereof. In certain other specific embodiments, the invention provides an anti-fungal pharmaceutical composition for topical application comprising an anti-fungal agent, a quarternary amino acid, a keratolytic agent; a lower alcohol; and water. In certain embodiments, the keratolytic agent is urea, ammonium thioglycolate, or a mixture thereof. | 12-06-2012 |
20130059915 | TREATMENT OF PAIN WITH TOPICAL DICLOFENAC - The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users. | 03-07-2013 |
20130065870 | TREATMENT OF PAIN WITH TOPICAL DICLOFENAC - The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users. | 03-14-2013 |
20130243701 | FOAMABLE FORMULATION - The present invention provides DMSO-containing foamable formulations, methods for preparation, and methods of treatment. The formulations can provide good permeability and bioavailability at the target site. Preferably, the formulations are useful for treating osteoarthritis. In one embodiment, the invention provides a foamable formulation for topical use, said formulation comprising DMSO, polyalkylene glycol alkyl ether, an active agent, a monohydric lower alcohol, a diol, and water. Preferably, the active agent is a non-steroidal anti-inflammatory drug, such as diclofenac sodium or ibuprofen. | 09-19-2013 |
20140178459 | COMPOSITIONS AND METHODS FOR TRANSDERMAL DELIVERY OF HORMONES AND OTHER MEDICINAL AGENTS - The invention provides transdermal delivery systems, medical kits, and methods for using the transdermal delivery systems and kits for medical applications, such as delivery of contraceptive agents to control fertility. | 06-26-2014 |
Patent application number | Description | Published |
20080221212 | TOPICAL FORMULATION - There is described a topical formulation. The topical formulation includes: (i) diclofenac or a pharmaceutically acceptable salt thereof, (ii) a first compound, and (iii) a second compound. The first compound and second compound are different, and each is selected from the group consisting essentially of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate and sodium lauryl sulfoacetate. It has been discovered that certain combination of compounds are excellent penetration enhancers and, as such, can be incorporated in a topical formulation to facilitate administration of diclofenac or a pharmaceutically acceptable salt thereof. The increased penetration enhancement can also lead to a reduction in the total concentration of skin irritants in the formulation. | 09-11-2008 |
20110028460 | TOPICAL FORMULATION - It has been discovered that certain combinations compounds are excellent penetration enhancers and, as such, can be incorporated in a topical formulation to facilitate administration of active agents. The increased penetration enhancement can also lead to a reduction in the total concentration of skin irritants in the formulation. There is described herein a topical formulation comprising (i) at least one active agent; (ii) a first compound, and (iii) a second compound, wherein the first compound and second compound are different, and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate and sodium lauryl sulfoacetate. | 02-03-2011 |
20110288123 | FORMULATIONS FOR THE TREATMENT OF ACUTE HERPES ZOSTER PAIN - The present invention provides compositions and methods that are useful for treatment of pain associated with acute herpes zoster. The aqueous compositions are non-stinging and non-irritating. | 11-24-2011 |
20120232152 | TOPICAL IBUPROFEN FORMULATIONS - The present application relates to a topical formulation comprising ibuprofen, a hydroalcoholic based solvent system, a C | 09-13-2012 |
20130041034 | Treatment of pain with topical diclofenac compounds - The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users. | 02-14-2013 |
20130079404 | TOPICAL FORMULATION - It has been discovered that certain combinations of compounds are excellent penetration enhancers and, as such, can be incorporated in a topical formulation to facilitate administration of active agents. The increased penetration enhancement can also lead to a reduction in the total concentration of skin irritants in the formulation. There is described herein a topical formulation comprising (i) an active agent selected from at least one of lidocaine and tetracaine; (ii) a first compound, and (iii) a second compound, wherein the first compound and second compound are different, and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate and sodium lauryl sulfoacetate. | 03-28-2013 |
20130136805 | FOAMABLE COMPOSITIONS OF STABILIZED CHLORITE - The present application relates to foamable compositions and foams comprising stabilized chlorite, including stabilized chlorite solutions such as Oxovasin™, and to medical uses thereof, in particular for wound healing. The foamable compositions comprise at least one foaming agent, stabilized chlorite, water and optionally, a buffering agent. | 05-30-2013 |
20130316020 | WOUND DRESSINGS COMPRISING CHLORITE - This application described a wound dressing comprising an absorbent material, an effective amount of chlorite and an amount of a base to provide a pH of the dressing material greater than or equal to about ( | 11-28-2013 |
20130337031 | TOPICAL FORMULATIONS, SYSTEMS AND METHODS - The present disclosure is drawn to topical formulations, transdermal systems, and related methods. In one embodiment, a topical formulation is provided that includes a local anesthetic, a first compound, and a second compound. The first compound and second compound are different and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate, and sodium lauryl sulfoacetate. | 12-19-2013 |
Patent application number | Description | Published |
20090132113 | SYSTEM AND METHOD FOR MANAGING MOBILE ASSET - A system includes a location determination unit for determining a geographic location of a mobile asset having an engine that produces one or more emissions during use; a memory for storing a plurality of predetermined characteristic profiles, the characteristic profiles including information regarding geographic location and at least one of engine emission levels, noise emission levels, fuel usage levels, power output, load manifest, or speed level; a processor in communication with the memory for accessing the characteristic profile for the determined location of the mobile asset and generating a control command responsive to a selected characteristic profile; and a control unit on board the mobile asset controlling an operation of the mobile asset responsive to the control command. Associated methods are provided. | 05-21-2009 |
20110216200 | LOCOMOTIVE WIRELESS VIDEO RECORDER AND RECORDING SYSTEM - An imaging system for generating images taken from a rail vehicle, the system including a camera configured to generate video data associated with a rail vehicle, and a processor configured to control recording of video data according to at least one of a variable frame rate or a variable resolution based on operating conditions of the rail vehicle. A method and non-transitory computer readable medium with instructions are also included. | 09-08-2011 |
20150070503 | VIDEO SYSTEM AND METHOD FOR DATA COMMUNICATION - A camera system and method capture image data with a camera, a data storage device electrically connected to the camera and configured to store the video data and/or a communication device electrically connected to the camera and configured to communicate the image data to a system receiver located remote from the camera. The system receiver may be located onboard a vehicle such that an operator can carry the camera off board the vehicle and communicate the image data back to the vehicle, when performing, for example, work on the vehicle or inspecting the vehicle or the environs of the vehicle. | 03-12-2015 |